Table 2.
Hardy-Weinberg equilibrium for DEFB-1 genotypes of vitiligo patients and control group.
DEFB-1 genotypes | Patients (n = 50) |
Controls (n = 50) |
||
---|---|---|---|---|
Observed | Expected | Observed | Expected | |
GG | 37 | 37.8 | 0 | 0.5 |
AG | 13 | 11.3 | 10 | 9 |
AA | 0 | 0.8 | 40 | 40.5 |
p-value | 0.290 | 0.432 |
HWE, Hardy-Weinberg equilibrium; n, number; DEFB-1, Defensin Beta-1.